[PDF][PDF] Platelet-activating factor.
SM Prescott, GA Zimmerman… - Journal of Biological …, 1990 - researchgate.net
Platelet-activating factor is a phospholipid with diverse potent physiological effects. Its
actions are achieved at concentrations as low as IO-'” M in some systems and almost always …
actions are achieved at concentrations as low as IO-'” M in some systems and almost always …
Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids
F Snyder - Proceedings of the Society for Experimental …, 1989 - journals.sagepub.com
I. Introduction In the autumn of 1979, three independent laboratories (1–3) described the
chemical structure of a new subclass of phospholipids that possessed biologic properties …
chemical structure of a new subclass of phospholipids that possessed biologic properties …
The intracellular retention of newly synthesized platelet-activating factor.
JM Lynch, PM Henson - Journal of immunology (Baltimore, Md …, 1986 - journals.aai.org
The ether phospholipid platelet-activating factor (PAF) has been generally assumed to be
released into the extracellular environment by the cells of origin, whereupon it effects its well …
released into the extracellular environment by the cells of origin, whereupon it effects its well …
[引用][C] Platelet‐activating factor: a mediator for clinicians
TA IMAIZUMI, DM STAFFORINI… - Journal of internal …, 1995 - Wiley Online Library
Platelet-activating factor (PAF) is the common name given to lO-alkyl-2-acetyl-sn-glycero-3-
phospho-choline (Fig. la: also. see refs 14). a biologically active phospholipid. It transmits …
phospho-choline (Fig. la: also. see refs 14). a biologically active phospholipid. It transmits …
[HTML][HTML] Platelet-activating factor: a phospholipid autacoid with diverse actions
ME Venable, GA Zimmerman, TM McIntyre… - Journal of lipid …, 1993 - Elsevier
Platelet-activating factor (PAF, 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent
biological mediator that exerts its effects in a variety of cells and tissues (1-3). This …
biological mediator that exerts its effects in a variety of cells and tissues (1-3). This …
Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
SB Hwang - Journal of Biological Chemistry, 1988 - ASBMB
Due to multiple molecular species of platelet-activating factor (PAF) and the existence of
high affinity binding sites in a variety of cells and tissues, possible existence of PAF receptor …
high affinity binding sites in a variety of cells and tissues, possible existence of PAF receptor …
Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.
F Bussolino, G Camussi, M Aglietta… - … (Baltimore, Md.: 1950 …, 1987 - journals.aai.org
Abstract Platelet-activating factor (PAF), but not its deacetylated and biologically inactive
metabolite lyso-PAF, in a dose dependent-manner (0.1 to 10 nM), induces human …
metabolite lyso-PAF, in a dose dependent-manner (0.1 to 10 nM), induces human …
Binding and metabolism of platelet-activating factor by human neutrophils.
JT O'Flaherty, JR Surles, J Redman… - The Journal of …, 1986 - Am Soc Clin Investig
Human polymorphonuclear neutrophils rapidly incorporated radiolabeled platelet-activating
factor, 1-O-[hexadecyl-9, 10-3H2]-2-acetyl-sn-glycero-3-phosphocholine ([3H] PAF), and …
factor, 1-O-[hexadecyl-9, 10-3H2]-2-acetyl-sn-glycero-3-phosphocholine ([3H] PAF), and …
[HTML][HTML] Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).
CA Demopoulos, RN Pinckard, DJ Hanahan - Journal of Biological …, 1979 - Elsevier
A glyceryl ether containing phosphoglyceride, 1-O-alkyl-2-acetyl-sn-glyceryl-3-
phosphorylcholine (Ac-GEPC), has been shown to have a biological activity …
phosphorylcholine (Ac-GEPC), has been shown to have a biological activity …
Platelet-activating factor (PAF): implications for coronary heart and vascular diseases
AM Evangelou - Prostaglandins, leukotrienes and essential fatty acids, 1994 - Elsevier
Platelet activating factor (PAF) research, could be divided into three periods. The first, which
could be named the 'pioneer period', started in the sixties, when a reaction involving …
could be named the 'pioneer period', started in the sixties, when a reaction involving …